Nika Pharmaceuticals Inc.
NIKA - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$429.91M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $429.91 Million |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $0 |
| Beta | -2.48 |
| Outstanding Shares | 1,051,689,224 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -5519.27 |
|---|---|
| PEG | -77265.51 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Nika Pharmaceuticals Inc.
0CEO: Dimitar Slavchev Savov
Nika Pharmaceuticals Inc., a pharmaceutical enterprise headquartered in Henderson, Nevada, focuses on the creation of medications to address a broad spectrum of health conditions. Its research and development efforts target serious disea...